A Chapel Hill-based company that has developed a cardiac simulation system has raised more than $300,000 in a private equity offering, according to a Securities and Exchange Commission filing.

KindHeart Inc. raised $305,696 from 10 investors, according to the filing. It is seeking to raise another $944,000.

In February, KindHeart raised some $600,000 and at that point had successfully landed some $1 million from a variety of angel investors.

The company was founded in 2011 based on technology developed for a complete cardiac surgery simulation system that makes a real pig heart behave just like a human heart during open-heart surgery.

  • VIDEO: Watch a video “Demonstration of Cardiac Simulator including Tachycardia, Ventricular Fibrillation, Cardioversion, Cannulation, Off Pump Coronary IMA Bypass, and Aortic Valve Replacement” from KindHeart at: https://www.youtube.com/watch?time_continue=2&v=J7pTCFIxlx4

Dr. Paul Ramphal built the simulator to provide his students clinical-level instruction at University of the West Indies to compensate for low patient flow.

KindHeart co-founder, Dr. Richard Feins, professor of surgery at UNC-Chapel Hill and then chairman of the American Board of Thoracic Surgery, collaborated with Ramphal to develop the first simulators for academic institutions.

KindHeart’s simulators were made in limited quantities in late 2015 and fully commercialized in 2016.

Private companies such as KindHeart relying on a Reg D exemption do not have to register their offering of securities with the SEC, but must file a Form D electronically with the SEC after they sell its securities.

KindHeart, the backstory

IT ALL STARTED WHEN…

KindHear was founded in 2011 based on technology developed for a complete cardiac surgery simulation system that makes a real pig heart behave just like a human heart during open-heart surgery.  Dr. Paul Ramphal built the simulator to provide his students clinical-level instruction at University of the West Indies to compensate for low patient flow. KindHeart co-founder, Dr. Richard Feins, Professor of Surgery at UNC Chapel Hill and then Chairman of the American Board of Thoracic Surgery, collaborated with Dr. Ramphal to develop the first simulators for academic institutions. Kindheart’s simulators were made in limited quantities in late 2015 and fully commercialized in 2016.

Today, KindHeart systems deliver unprecedented value by providing a realistic demonstration environment for abdominal, thoracic, and cardiac surgical procedures. As opposed to cadavers, live animals, or live humans, our proprietary platform is predictable, flexible, and scalable.  It is easy to simulate adverse conditions surgeons might encounter during operations, rectify mistakes and pause during a simulated procedure.  The immersive nature of real tissue, natural movement, bleeding and other cues from a surgical environment provides doctors with a much richer experience vs. virtual reality or static simulation.

KindHeart is also developing tele-simulation capabilities to allow device manufacturers to offer surgical sessions, which can be performed remotely and eliminate the need for the surgeon to travel to a remote training center and lose several days of productive work.

Source: KindHeart

Note: North Carolina Business News Wire contributed to this report.